Imagen de Portada

Warning from heart: An unusual case report of isolated Rosai‐Dorfman disease in an Asian

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Ming‐Xuan Zhang, Bo‐Wen Zhao, Bei Wang, Ji‐Ling Zeng
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	British Journal of Haematology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Successful treatment of relapsed idiopathic multicentric Castleman disease–idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report
por: Yu‐han Gao, et al.
Publicado: (2024)

An unusual case of paroxysmal cold haemoglobinuria in a middle‐aged female
por: Jordan Burgess, et al.
Publicado: (2024)

Long‐term remission of TP53‐mutated therapy‐related acute myeloid leukaemia following allogeneic stem cell transplantation in a heart transplant recipient: A case report and literature review
por: Annie Xiao, et al.
Publicado: (2024)

HOX11 gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia
por: Mingyan Zhong, et al.
Publicado: (2025)

Ruxolitinib‐based regimen in children with autoimmune disease or autoinflammatory disease‐related haemophagocytic lymphohistiocytosis
por: Zishi Fang, et al.
Publicado: (2024)

MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report
por: Xiang Zhang, et al.
Publicado: (2024)

Second primary malignancies in Asian chronic lymphocytic leukaemia patients: A Taiwan Cancer Registry Study
por: Yi‐Wei Lee, et al.
Publicado: (2026)

Clinical and haematological features of hyperhaemolysis in sickle cell disease: A case series from two tertiary care centres
por: Jaehyup Kim, et al.
Publicado: (2025)

Elranatamab therapy in relapsed refractory multiple myeloma patients with chronic kidney disease: A case series
por: Gráinne Marron, et al.
Publicado: (2026)

Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single‐centre, retrospective study
por: Yu‐Han Gao, et al.
Publicado: (2024)

Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report
por: E. Laspa, et al.
Publicado: (2025)

The role of proliferating stem‐like plasma cells in relapsed or refractory multiple myeloma: Insights from single‐cell RNA sequencing and proteomic analysis
por: Jiadai Xu, et al.
Publicado: (2024)

The heart of VIALE‐A: Cardiac complications of hypomethylating agents and venetoclax in acute myeloid leukaemia
por: Shyam A. Patel
Publicado: (2024)

Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study
por: Maddalena Casale, et al.
Publicado: (2024)

A CD10‐negative adult B‐lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature
por: Huan‐You Wang, et al.
Publicado: (2024)

POU6F2, a novel fusion partner of NUP98 in acute myeloid leukaemia: A case report
por: Yu Jeong Choi, et al.
Publicado: (2024)

Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia‐related mutations in first remission
por: Ling Jiang, et al.
Publicado: (2024)

Personalized therapy guided by single‐cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report
por: Rong Wang, et al.
Publicado: (2024)

Immune‐mediated thrombotic thrombocytopenic purpura with ischaemic cerebral infarction preceding onset of thrombocytopenia and microangiopathic haemolytic anaemia: A case report
por: Masahito Uchihara, et al.
Publicado: (2024)

Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium
por: Jennifer N. Longoria, et al.
Publicado: (2024)

Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency
por: Erin L. Frost, et al.
Publicado: (2024)

Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis
por: Yosra M. Aljawai, et al.
Publicado: (2024)

Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation
por: Tingting Zhang, et al.
Publicado: (2024)

Correction to ‘Personalized therapy guided by single‐cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report’
Publicado: (2025)

STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia
por: Xiuli Xu, et al.
Publicado: (2024)

Taiwan consensus on pulmonary chronic graft‐versus‐host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation ( TBMT ) and Taiwan Society of Pulmonary and Critical Care Medicine ( TSPCCM )
por: Xavier Cheng‐Hong Tsai, et al.
Publicado: (2025)

CD19‐CAR T‐cell therapy with sorafenib in post‐HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature
por: A. Oszer, et al.
Publicado: (2024)

Impact of voxelotor discontinuation on patients with sickle cell disease
por: Jin Han, et al.
Publicado: (2026)

Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China
por: Yan‐ting Liu, et al.
Publicado: (2024)

Clinical features and treatment outcomes of POEMS ‐associated Castleman disease
por: Grace Lau, et al.
Publicado: (2026)

Impact of elranatamab on quality of life: Patient‐reported outcomes from MagnetisMM‐3
por: Mohamad Mohty, et al.
Publicado: (2024)

A sinister case of pseudothrombocytosis
por: Melissa N. Loyzer, et al.
Publicado: (2024)

Aligning patient‐reported priorities in immune thrombocytopenia with clinical and regulatory advances: Insights from rilzabrutinib
por: Muhammad Ammar Hasan, et al.
Publicado: (2025)

Diagnostic impact of exome sequencing in haemophagocytic lymphohistiocytosis: A report from the Italian reference centre
por: Aurora Chinnici, et al.
Publicado: (2025)

Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
por: Tian‐shu Yu, et al.
Publicado: (2025)

Alterations in the humoral immunophenotype in sickle cell disease
por: E. Vistica Sampino, et al.
Publicado: (2025)

Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India
por: Niteesh Bharadwaj, et al.
Publicado: (2024)

Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia
por: Li‐Xin Wu, et al.
Publicado: (2025)

Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality
por: Le Yin, et al.
Publicado: (2024)

Controversies in the pathophysiology of leg ulcers in sickle cell disease
por: Judith Catella, et al.
Publicado: (2024)